The notices it replaced
- Reissues: PAR-24-072 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- 2 steps back: PAR-21-035 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- 3 steps back: PAR-18-559 Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Who won it before
288 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $193,123,431 in first-year total cost, median $660,423.
Most frequent study sections
- Cancer Prevention Study Section[CPSS]23
- Interventions to Prevent and Treat Addictions Study Section[IPTA]21
- Biobehavioral Medicine and Health Outcomes Study Section[BMHO]20
- Interdisciplinary Clinical Care in Specialty Care Settings Study Section[ICSC]18
- Health Services: Quality and Effectiveness Study Section[HSQE]14
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL14
- UNIVERSITY OF TX MD ANDERSON CAN CTR12
- SLOAN-KETTERING INST CAN RESEARCH10
- DUKE UNIVERSITY9
- MEDICAL UNIVERSITY OF SOUTH CAROLINA9
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Evaluating the Impact of Accessible and Scalable Digital Interventions to Address Co-Occurring Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design1R01CA295673-01A1 · under PAR-24-072 | CHOW, PHILIP | UNIVERSITY OF VIRGINIA, VA | $3,355,681 | MESH |
| 2025 | Remotely-Delivered Cognitive Behavioral Stress Management Effects on Cancer-Accelerated Aging in Older, Distressed Breast Cancer Survivors1R01CA296071-01A1 · under PAR-24-072 | ANTONI, MICHAEL HOWARD | UNIVERSITY OF MIAMI CORAL GABLES, FL | $2,746,080 | BMHO |
| 2025 | A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression1R01CA295877-01 · under PAR-24-072 | CHAK, AMITABHMARKOWITZ, SANFORD D.WILLIS, JOSEPH EDWARD | CASE WESTERN RESERVE UNIVERSITY, OH | $1,623,261 | CPSS |
| 2025 | Randomized Trial of a Targeted Palliative Care Intervention for Patients with Metastatic Breast Cancer1R01CA299956-01 · under PAR-24-072 | TEMEL, JENNIFER SUE | MASSACHUSETTS GENERAL HOSPITAL, MA | $858,166 | ICSC |
| 2025 | A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure1R37CA300969-01 · under PAR-24-072 | UPSHAW, JENICA | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $818,625 | ZRG1 |
| 2025 | Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship1R37CA303094-01 · under PAR-24-072 | PEREZ-LOUGEE, GISELLE KATIRIA | MASSACHUSETTS GENERAL HOSPITAL, MA | $817,829 | ICSC |
| 2025 | Evaluation of Cardiovascular Health Outcomes among Survivors 2 (ECHOS-2)1R01CA297448-01A1 · under PAR-24-072 | EHRHARDT, MATTHEW JAMESWATERS, ERIKA A | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | $772,418 | CMGC |
| 2025 | A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults with Cancer1R37CA302422-01 · under PAR-24-072 | MCGRADY, MEGHAN EILEEN | CINCINNATI CHILDRENS HOSP MED CTR, OH | $763,161 | CMGC |
| 2025 | Providing nicotine replacement therapy to enhance the efficacy of a smoking cessation smartphone app for Hispanic adults1R01CA298383-01 · under PAR-24-072 | BRICKER, JONATHAN B | FRED HUTCHINSON CANCER CENTER, WA | $757,913 | HPC |
| 2025 | A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression1R01CA296175-01 · under PAR-24-072 | TANG, LIYEARY, KAREN HYE-CHEON KIM | ROSWELL PARK CANCER INSTITUTE CORP, NY | $717,150 | LCBH |
| 2025 | The MIND-BC Study: MIND diet for Breast cancer Cognition1R01CA299480-01 · under PAR-24-072 | CROWDER, SYLVIA | H. LEE MOFFITT CANCER CTR & RES INST, FL | $713,235 | ZRG1 |
| 2025 | Algorithm-enabled Patients Activated in Cancer care through Teams (A-PACT) toimprove goals of care communication for people with cancer1R37CA296075-01 · under PAR-24-072 | MANZ, CHRISTOPHERPARIKH, RAVI BHARATPATEL, MANALI I | EMORY UNIVERSITY, GA | $708,091 | ZRG1 |
| 2025 | Youth Vaping Prevention through Immersive Technology1R01CA294027-01A1 · under PAR-24-072 | CAMENGA, DEEPA RHIEFTJE, KIMBERLY D | YALE UNIVERSITY, CT | $705,618 | HPC |
| 2025 | Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL)1R01CA293974-01A1 · under PAR-24-072 | ROTEMBERG, VERONICA MIRIAM | SLOAN-KETTERING INST CAN RESEARCH, NY | $700,611 | CTIS |
| 2025 | Investigating Efficacious E-Cigarette Interventions and Cessation Effects on Cancer-Related Biomarkers: A Randomized Trial of Varenicline in Adults1R01CA296186-01 · under PAR-24-072 | FUCITO, LISA MTOLL, BENJAMIN ANDREW | YALE UNIVERSITY, CT | $687,995 | IPTA |
| 2025 | A randomized trial of charcoal-filtered cigarettes on product perceptions, smoking behaviors, and toxicant exposure1R37CA296976-01A1 · under PAR-24-072 | MERCINCAVAGE, MELISSA | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $687,511 | LHB |
| 2025 | Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma2R01CA241164-07 · under PAR-24-072 | CHHATWAL, JAGPREETIYER, PRASAD G.KISIEL, JOHN | MAYO CLINIC ARIZONA, AZ | $678,428 | ZRG1 |
| 2025 | A decisional intervention for older adults with acute myeloid leukemia and their caregivers1R01CA288318-01A1 · under PAR-24-072 | LOH, KAH POH | UNIVERSITY OF ROCHESTER, NY | $678,204 | ICSC |
| 2025 | Improving Care Delivery for Individuals with Mental Illness and Cancer Across a Cancer Center Network.1R37CA300110-01 · under PAR-24-072 | IRWIN, KELLY EDWARDS | MASSACHUSETTS GENERAL HOSPITAL, MA | $673,096 | ICSC |
| 2025 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC)1R01CA290863-01A1 · under PAR-24-072 | HUNDLEY, WILLIAM GREGORY | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $671,757 | CCHS |
| 2025 | Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES1R01CA296402-01 · under PAR-24-072 | STEEL, JENNIFER L. | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $669,324 | HSQE |
| 2025 | Weight management and Black American women: Targeting social networks as a strategy to improve outcomes1R01CA296842-01 · under PAR-24-072 | FITZGIBBON, MARIAN L.MOLINA, YAMILE | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $665,368 | LCBH |
| 2025 | Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit1R01CA302758-01 · under PAR-24-072 | AUDRAIN-MCGOVERN, JANET E | UNIVERSITY OF PENNSYLVANIA, PA | $663,554 | IPTA |
| 2025 | Proactive Outreach and Streamlined Genetic Testing in Prostate Cancer Survivors1R01CA296911-01A1 · under PAR-24-072 | KINNEY, ANITA Y.SCHWARTZ, MARC D | GEORGETOWN UNIVERSITY, DC | $663,383 | HSQE |
| 2025 | Moving Forward with Multiple Myeloma1R01CA300310-01 · under PAR-24-072 | D'SOUZA, ANITASHEEAN, PATRICIA MAUREENSTOLLEY, MELINDA R | MEDICAL COLLEGE OF WISCONSIN, WI | $657,844 | BMHO |
| 2025 | Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer1R01CA300028-01A1 · under PAR-24-072 | ARCH, JOANNA J | UNIVERSITY OF COLORADO, CO | $656,046 | BMHO |
| 2025 | Interventions to Decrease Cancer Information Avoidance1R01CA276430-01A1 · under PAR-24-072 | OROM, HEATHER | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $637,596 | SPIP |
| 2025 | iC9-CAR.CSPG4 CAR-T Cells for Head and Neck Squamous Cell Carcinoma1R01CA296807-01 · under PAR-24-072 | WEISS, JARED | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $627,456 | CIC |
| 2025 | A Randomized Factorial Trial of Varenicline with Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation1R01CA298165-01 · under PAR-24-072 | AHLUWALIA, JASJIT SINGHKENDZOR, DARLA ELIZABETH | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $625,201 | IPTA |
| 2025 | A Novel Harm Reduction Approach for Oncology Outpatients who Smoke and Refuse Traditional Tobacco Treatment1R01CA293735-01A1 · under PAR-24-072 | ROJEWSKI, ALANASMITH, TRACY TAYLOR | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $619,175 | IPTA |
| 2025 | Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa1R37CA306827-01 · under PAR-24-072 | MUNGO, CHEMTAI | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $605,863 | HCAC |
| 2025 | Randomized Trial of a Multi-Disciplinary Intervention for Patients with Chronic Grant-Versus-Host Disease1R01CA296889-01 · under PAR-24-072 | EL-JAWAHRI, AREEJTRAEGER, LARA | UNIVERSITY OF MIAMI CORAL GABLES, FL | $599,339 | BMHO |
| 2025 | Using novel behavioral economic measures to characterize dual marijuana and tobacco use in young adults1R01CA289409-01A1 · under PAR-24-072 | ASTON, ELIZABETHCASSIDY, RACHEL N | BROWN UNIVERSITY, RI | $594,099 | ARM |
| 2025 | Efficacy of a multi-level intervention designed to promote adherence to WCRF/AICR dietary guidelines for cancer prevention1R01CA288323-01A1 · under PAR-24-072 | BUTRYN, MEGHAN | DREXEL UNIVERSITY, PA | $588,359 | LCBH |
| 2025 | Efficacy of a group-based videoconference intervention to increase physical activity in cancer survivors1R01CA296965-01 · under PAR-24-072 | LEACH, HEATHER JEAN | COLORADO STATE UNIVERSITY, CO | $414,446 | LCBH |
| 2024 | Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation1R01CA278938-01A1 · under PAR-21-035 | CINCIRIPINI, PAUL MICHAELROBINSON, JASON D | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $923,199 | IPTA |
| 2024 | Dual Use Cessation: A MOST Screening Trial to Identify Effective Interventions to Help People Who Smoke and Vape1R01CA290895-01 · under PAR-21-035 | BAKER, TIMOTHY BPIPER, MEGAN E | UNIVERSITY OF WISCONSIN-MADISON, WI | $876,297 | ZRG1 |
| 2024 | Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)1R01CA286563-01A1 · under PAR-21-035 | FRIEDMAN, DANIELLE | SLOAN-KETTERING INST CAN RESEARCH, NY | $794,530 | ZRG1 |
| 2024 | AYA ACCESS Study: An enhanced eHealth and Chat-bot enabled delivery model for clinical genetic services in community AYA cancer patients1R01CA284748-01A1 · under PAR-21-035 | BRADBURY, ANGELA R.HENDERSON, TARA OLIVE | UNIVERSITY OF PENNSYLVANIA, PA | $754,398 | ZRG1 |
| 2024 | MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication1R01CA283501-01A1 · under PAR-21-035 | BOUCHARD, ELIZABETHKELLY, KARA M | ROSWELL PARK CANCER INSTITUTE CORP, NY | $754,264 | CMGC |
| 2024 | Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors1R01CA289547-01 · under PAR-21-035 | ARCH, JOANNA JWRIGHT, ALEXI A | DANA-FARBER CANCER INST, MA | $748,174 | ICSC |
| 2024 | Enhanced Pain Coping in Cancer (EPIC)1R01CA285746-01A1 · under PAR-21-035 | GARLAND, ERIC LEEHANLEY, ADAM WESLEYMAO, JUN J | SLOAN-KETTERING INST CAN RESEARCH, NY | $732,536 | BMHO |
| 2024 | HEME-Hospice: An Intervention to improve Hospice Use for Patients with Hematologic Malignancies1R37CA289639-01 · under PAR-21-035 | ODEJIDE, OREOFE OLUKEMI | DANA-FARBER CANCER INST, MA | $731,526 | ICSC |
| 2024 | Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol use among PWH in Nairobi, Kenya1R01CA288235-01A1 · under PAR-21-035 | HIMELHOCH, SETH SKAHLER, CHRISTOPHER W.KOECH, EMILYSHUTER, JONATHAN | UNIVERSITY OF CHICAGO, IL | $728,006 | HIBI |
| 2024 | Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice (PREDICT)1R01CA288530-01 · under PAR-21-035 | ATLAS, STEVEN JHAAS, JENNIFER S | MASSACHUSETTS GENERAL HOSPITAL, MA | $723,513 | ZRG1 |
| 2024 | Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients1R01CA292116-01 · under PAR-21-035 | RINI, CHRISTINE | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $716,911 | BMHO |
| 2024 | Colorectal Cancer Screening with Optical Coherence Tomography1R01CA280972-01A1 · under PAR-21-035 | TEARNEY, GUILLERMO J | MASSACHUSETTS GENERAL HOSPITAL, MA | $710,880 | ITD |
| 2024 | Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings1R01CA282682-01A1 · under PAR-21-035 | WAGNER, LYNNE I. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $709,050 | BMHO |
| 2024 | Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking: A Randomized Controlled Trial1R01CA293229-01 · under PAR-21-035 | HEFFNER, JAIMEEMCCLURE, JENNIFER B | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $707,367 | IPTA |
| 2024 | A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers1R01CA291735-01 · under PAR-21-035 | HAY, JENNIFER LKANETSKY, PETER A | H. LEE MOFFITT CANCER CTR & RES INST, FL | $706,771 | HSQE |
| 2024 | FITting noninvasive testing into Lynch syndrome colorectal cancer surveillance: a multicenter, prospective trial1R01CA287257-01 · under PAR-21-035 | KASTRINOS, FAYKUPFER, SONIASTOFFEL, ELENA MARTINEZ | UNIVERSITY OF CHICAGO, IL | $701,911 | HSQE |
| 2024 | Addressing financial hardship in adolescent and young adult cancer survivors: Efficacy and implementation of a multilevel intervention in community-based oncology practices1R01CA282653-01A1 · under PAR-21-035 | BIRKEN, SARAH ABIGAILSALSMAN, JOHN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $699,517 | HPC |
| 2024 | Integrating Breast Cancer and Cardiovascular Disease Risk to Explore Decision-Making for Chemoprevention Among Racially/Ethnically Diverse Women at High Risk for Breast Cancer1R01CA293927-01 · under PAR-21-035 | CREW, KATHERINE DKUKAFKA, RITA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $684,333 | ZRG1 |
| 2024 | Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)1R01CA285925-01A1 · under PAR-21-035 | FLYNN, KATHRYN ENEUNER, JOAN MARIE | MEDICAL COLLEGE OF WISCONSIN, WI | $678,927 | ICSC |
| 2024 | Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma1R01CA291965-01 · under PAR-21-035 | DANIEL-MACDOUGALL, CARRIEMCQUADE, JENNIFER LEIGHWARGO, JENNIFER A. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $678,399 | CONC |
| 2024 | weSipSmarter: An efficacy trial to reduce sugary beverages among rural Head Start parent-child dyads1R01CA282436-01A1 · under PAR-21-035 | ZOELLNER, JAMIE | UNIVERSITY OF VIRGINIA, VA | $670,209 | LCBH |
| 2024 | Expanding access to colorectal cancer screening through community pharmacies: The PharmFIT study1R01CA279010-01A1 · under PAR-21-035 | BRENNER, ALISON TSHAH, PARTH D | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $666,969 | HSQE |
| 2024 | Symptom Management and Transitioning to Engagement with Post-treatment Care for Adolescent and Young Adult Cancer Survivors (AYA STEPS)1R37CA283353-01A1 · under PAR-21-035 | DORFMAN, CAROLINE | DUKE UNIVERSITY, NC | $664,259 | ICSC |
| 2024 | Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer Disparities in Appalachia1R01CA289551-01 · under PAR-21-035 | KELLER-HAMILTON, BRITTNEY LWAGENER, THEODORE LEE | OHIO STATE UNIVERSITY, OH | $661,139 | IPTA |
| 2024 | Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes1R01CA283332-01A1 · under PAR-21-035 | O'CONNOR, PATRICK J | HEALTHPARTNERS INSTITUTE, MN | $657,621 | ZRG1 |
| 2024 | Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology1R01CA288515-01 · under PAR-21-035 | HUI, DAVID | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $655,203 | ICSC |
| 2024 | Efficacy Trial of Healthy Juntos: A Family-based Digital Lifestyle Intervention for Hispanic Adolescents and their Parents1R01CA289519-01 · under PAR-21-035 | ST. GEORGE, SARA MIJARES | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $650,412 | LCBH |
| 2024 | Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer1R01CA289486-01 · under PAR-21-035 | MOSHER, CATHERINE E | INDIANA UNIVERSITY INDIANAPOLIS, IN | $645,910 | BMHO |
| 2024 | Evaluating a Multilevel Intervention to Increase Colonoscopic Follow-up after Abnormal Stool-based Colorectal Cancer Screening in a Community Safety-Net Setting1R01CA292236-01 · under PAR-21-035 | GLENN, BETH A.MAY, FOLASADE POPOOLA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $622,913 | HSQE |
| 2024 | Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers1R01CA290541-01A1 · under PAR-21-035 | AUDRAIN-MCGOVERN, JANET E | UNIVERSITY OF PENNSYLVANIA, PA | $620,313 | ARM |
| 2024 | BMT-CARE: Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation1R01CA282182-01A1 · under PAR-21-035 | EL-JAWAHRI, AREEJJACOBS, JAMIE MICHELE | MASSACHUSETTS GENERAL HOSPITAL, MA | $619,062 | ICSC |
| 2024 | The role of flavor in the substitutability of e-cigarettes for combustible cigarettes among persistent smokers1R01CA287474-01 · under PAR-21-035 | AUDRAIN-MCGOVERN, JANET E | UNIVERSITY OF PENNSYLVANIA, PA | $613,178 | ARM |
| 2024 | Multilevel RCT of Rural Community Sun Safety for Young Children in Sports1R01CA282219-01A1 · under PAR-21-035 | TERCYAK, KENNETHWU, YELENA PING | UNIVERSITY OF UTAH, UT | $604,703 | HPC |
| 2024 | Randomized controlled trial of varenicline to treat tobacco and cannabis co-use.1R01CA290842-01A1 · under PAR-21-035 | MCCLURE, ERIN A | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $602,786 | IPTA |
| 2024 | Title: Multi-Site Randomized Controlled Trial of a Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors1R01CA295109-01 · under PAR-21-035 | EL-JAWAHRI, AREEJ | MASSACHUSETTS GENERAL HOSPITAL, MA | $602,526 | BMHO |
| 2024 | Effects of a telehealth exercise program for rural cancer survivors with cancer-related fatigue including integrated longitudinal assessments of objective physical function and fatty acid oxidation1R01CA292482-01 · under PAR-21-035 | MARKER, RYAN J | UNIVERSITY OF COLORADO DENVER, CO | $594,734 | CMGC |
| 2024 | Communicating for Health Equity in Digital Environments1R01CA289552-01 · under PAR-21-035 | POPOVA, LYUDMILA | GEORGIA STATE UNIVERSITY, GA | $593,747 | ZRG1 |
| 2024 | A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention to Promote Guideline-Concordant Colorectal Cancer Surveillance1R01CA293394-01 · under PAR-21-035 | HAWLEY, SARAH TVEENSTRA, CHRISTINE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $591,691 | ZRG1 |
| 2024 | Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia1R01CA288550-01 · under PAR-21-035 | EL-JAWAHRI, AREEJ | MASSACHUSETTS GENERAL HOSPITAL, MA | $591,372 | ICSC |
| 2024 | Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer1R01CA291768-01 · under PAR-21-035 | WINGER, JOSEPH GILES | DUKE UNIVERSITY, NC | $578,467 | BMHO |
| 2024 | mHealth Intervention to Support Symptom Communication for Children with Cancer1R01CA291977-01 · under PAR-21-035 | LINDER, LAURI A | UNIVERSITY OF UTAH, UT | $564,300 | CIDH |
| 2024 | Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients1R01CA291888-01 · under PAR-21-035 | KELLEHER, SARAH | DUKE UNIVERSITY, NC | $561,734 | ZRG1 |
| 2024 | Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)1R01CA279021-01A1 · under PAR-21-035 | HUH, WARNER KINGMANGA, SIMON | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $561,565 | HSQE |
| 2024 | Lymphedema Prevention Through Immediate Lymphatic Reconstruction1R01CA292908-01 · under PAR-21-035 | ALDRICH, MELISSA BSCHAVERIEN, MARK V | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $516,114 | IVPP |
| 2024 | Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings1R01CA282416-01A1 · under PAR-21-035 | BOWER, JULIENNE EGANZ, PATRICIA A. | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $515,404 | CMGC |
| 2024 | Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention1R01CA285674-01A1 · under PAR-21-035 | REESE, JENNIFER BARSKY | RESEARCH INST OF FOX CHASE CAN CTR, PA | $475,317 | BMHO |
| 2024 | Meaning-Centered Psychotherapy to Meet Palliative Care Needs of Cancer Caregivers1R01CA285621-01 · under PAR-21-035 | APPLEBAUM, ALLISON | SLOAN-KETTERING INST CAN RESEARCH, NY | $195,866 | SPIP |
| 2024 | Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV1R01CA285331-01A1 · under PAR-21-035 | ASHARE, REBECCAVILARDAGA, ROGER | DUKE UNIVERSITY, NC | $1 | ZRG1 |
| 2023 | Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)1R01CA276652-01A1 · under PAR-21-035 | ABE, HIROYUKIKARCZMAR, GREGORY S.OLOPADE, OLUFUNMILAYO F. | UNIVERSITY OF CHICAGO, IL | $1,268,206 | CIDH |
| 2023 | Screening strategies and social determinants of health among people with high risk of anal cancer1R01CA285198-01 · under PAR-21-035 | FLOWERS, LISA C.ROSA-CUNHA, ISABELLAXIAO, CANHUA | EMORY UNIVERSITY, GA | $1,046,509 | HCCS |
| 2023 | Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy1R01CA276040-01A1 · under PAR-21-035 | HILL, JOSHUA AIDENPERALES, MIGUEL-ANGEL | FRED HUTCHINSON CANCER CENTER, WA | $930,383 | CONC |
| 2023 | Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy1R01CA281301-01A1 · under PAR-21-035 | LINDAU, STACY TESSLER | UNIVERSITY OF CHICAGO, IL | $844,117 | BNVT |
| 2023 | Refer 2 Quit: Proactive Promotion of Tobacco Use Treatment for Underserved Household Members Who Smoke through Pediatric Primary Care1R37CA282153-01 · under PAR-21-035 | JENSSEN, BRIAN P. | CHILDREN'S HOSP OF PHILADELPHIA, PA | $779,874 | IPTA |
| 2023 | Re-Engaging AYA Survivors in Cancer-Related Healthcare (REACH): A Sequential Multiple Assignment Randomized Trial (SMART)1R01CA273328-01A1 · under PAR-21-035 | SCHWARTZ, LISA A | CHILDREN'S HOSP OF PHILADELPHIA, PA | $756,425 | ICSC |
| 2023 | A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer1R01CA282165-01 · under PAR-21-035 | GRABOYES, EVAN MICHAEL | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $751,693 | HSQE |
| 2023 | Using a SMART design to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors1R01CA270441-01A1 · under PAR-21-035 | GREENLEE, HEATHER | FRED HUTCHINSON CANCER CENTER, WA | $747,975 | LCBH |
| 2023 | Trial of a harm reduction strategy for people with HIV who smoke cigarettes1R01CA275521-01A1 · under PAR-21-035 | SHUTER, JONATHAN | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $745,331 | HIBI |
| 2023 | Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial1R01CA284687-01A1 · under PAR-21-035 | BRICKER, JONATHAN B | FRED HUTCHINSON CANCER CENTER, WA | $744,186 | HPC |
| 2023 | Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations1R01CA282149-01 · under PAR-21-035 | VAN CLEAVE, JANET H | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $733,528 | ZRG1 |
| 2023 | Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes1R01CA280081-01 · under PAR-21-035 | DORFF, TANYAFREEDLAND, STEPHEN JAYLIN, PAO-HWA | CEDARS-SINAI MEDICAL CENTER, CA | $722,345 | CPSS |
| 2023 | Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers1R01CA282223-01 · under PAR-21-035 | HOEPPNER, BETTINA B. | MASSACHUSETTS GENERAL HOSPITAL, MA | $706,777 | IPTA |
| 2023 | Optimizing psychosocial intervention for breast cancer-related sexual morbidity: A factorial trial using the National Cancer Institute Community Oncology Research Program (NCORP) network1R37CA269776-01A1 · under PAR-21-035 | SHAFFER, KELLY MCLEAN | UNIVERSITY OF VIRGINIA, VA | $705,130 | BMHO |
| 2023 | Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers1R01CA276035-01A1 · under PAR-21-035 | MILBURY, KATHRIN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $694,107 | ICSC |
| 2023 | Multisite Implementation of COMPRENDO (ChildhOod Malignancy Peer REsearch NavigatiOn) to improve participation of Hispanic children in cancer clinical trials1R01CA279945-01 · under PAR-21-035 | ARISTIZABAL, PAULA | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $692,684 | HHD |
| 2023 | Digital Self-Management and Peer Mentoring Intervention to Improve the Transition from Pediatric to Adult Health Care for Childhood Cancer Survivors1R01CA282147-01 · under PAR-21-035 | DEVINE, KATIE A | RUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ | $690,045 | CMGC |
| 2023 | Managing symptoms and psychological distress during oral anti-cancer treatment1R01CA279472-01 · under PAR-21-035 | BADGER, TERRY ACRANE, TRACY ESIKORSKII, ALLA | MICHIGAN STATE UNIVERSITY, MI | $689,739 | BMHO |
| 2023 | The impact of cannabis and tobacco/nicotine product co-use in young adults: Prospective cessation evaluation and substitution1R01CA276066-01A1 · under PAR-21-035 | MCCLURE, ERIN A | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $689,656 | ZRG1 |
| 2023 | Epigallocatechin gallate for prevention of lethal cirrhosis complications1R01CA282178-01 · under PAR-21-035 | HOSHIDA, YUJINSINGAL, AMIT | UT SOUTHWESTERN MEDICAL CENTER, TX | $684,526 | HBPP |
| 2023 | Optimizing a Social Connectedness Intervention for Young Adults with Cancer1R01CA276176-01A1 · under PAR-21-035 | FREDRICKSON, BARBARA LEELAZARD, ALLISON JOAN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $680,456 | SPIP |
| 2023 | The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer1R01CA281220-01 · under PAR-21-035 | SMITH, MICHAEL TWILDER COUGHLIN, JANELLE | JOHNS HOPKINS UNIVERSITY, MD | $679,559 | LCBH |
| 2023 | A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors1R01CA276143-01A1 · under PAR-21-035 | HOYT, MICHAEL A | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $672,977 | BMHO |
| 2023 | A Randomized Controlled Trial to Improve Health Insurance Literacy and Surveillance among Young Adult Cancer Survivors1R01CA276825-01A1 · under PAR-21-035 | KIRCHHOFF, ANNE CPARK, ELYSE R. | UNIVERSITY OF UTAH, UT | $672,704 | ICSC |
| 2023 | Optimization of a personalized skin cancer risk intervention for at-risk young adults1R01CA266302-01A1 · under PAR-21-035 | HAY, JENNIFER LWU, YELENA PING | UNIVERSITY OF UTAH, UT | $671,963 | ZRG1 |
| 2023 | Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery1R01CA272565-01A1 · under PAR-21-035 | COHEN, LORENZO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $669,504 | ICSC |
| 2023 | PREVENT - Practice-based Approaches to Promote HPV Vaccination1R01CA279973-01 · under PAR-21-035 | KEPKA, DEANNA LEE | UNIVERSITY OF UTAH, UT | $666,739 | SIHH |
| 2023 | Understanding and addressing rejection of personalized cancer risk information1R01CA279953-01 · under PAR-21-035 | SCHERER, LAURA D.WATERS, ERIKA A | UNIVERSITY OF COLORADO DENVER, CO | $660,513 | SPIP |
| 2023 | Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial1R01CA274716-01A1 · under PAR-21-035 | TAYLOR, KATHRYN L | GEORGETOWN UNIVERSITY, DC | $660,333 | HSQE |
| 2023 | A Randomized Controlled Trial to Evaluate a Novel Treatment Strategy for Body Image-Related Distress Among Head and Neck Cancer Survivors1R37CA269385-01A1 · under PAR-21-035 | GRABOYES, EVAN MICHAEL | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $658,153 | LCBH |
| 2023 | Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients1R01CA272680-01 · under PAR-21-035 | SADIGH, GELAREH | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $652,687 | ODHS |
| 2023 | Evaluating a remotely delivered, digital health CRC screening intervention among racially diverse patients of a community health center1R01CA273331-01A1 · under PAR-21-035 | FRERICHS, LEAH M. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $650,993 | CMGC |
| 2023 | Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC1R01CA284860-01 · under PAR-21-035 | BRYAN, ANGELAHUTCHISON, KENT E. | UNIVERSITY OF COLORADO, CO | $650,978 | BMHO |
| 2023 | Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity1R01CA273221-01A1 · under PAR-21-035 | CHENEY, MARSHALLSMITS, JASPERZVOLENSKY, MICHAEL J. | UNIVERSITY OF TEXAS AT AUSTIN, TX | $648,024 | IPTA |
| 2023 | Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors1R01CA270111-01A1 · under PAR-21-035 | LAROSE, JESSICA GOKEEVALLE, CARMINA G | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $647,947 | LCBH |
| 2023 | Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial1R01CA276222-01 · under PAR-21-035 | GANZ, PATRICIA A.MCDONALD, BRENNA CVON AH, DIANE MARIE | OHIO STATE UNIVERSITY, OH | $639,125 | BMHO |
| 2023 | Community Services Navigation to Advance Health Equity in Breast Cancer Screening1R01CA282409-01 · under PAR-21-035 | ONEGA, TRACYOZANNE, ELISSA MARY | UNIVERSITY OF UTAH, UT | $638,074 | HHD |
| 2023 | Testing the efficacy of a decision aid and planning tool for family building after cancer1R37CA282148-01 · under PAR-21-035 | BENEDICT, CATHERINE | STANFORD UNIVERSITY, CA | $632,887 | CMGC |
| 2023 | Evaluation of a telehealth oncofertility care intervention in adolescent and young adult cancer patients: a stepped wedge cluster randomized controlled trial1R01CA271104-01A1 · under PAR-21-035 | SU, HUI-CHUN IRENE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $632,351 | ICSC |
| 2023 | A clinical trial of adaptive treatment for early smoking cessation relapse1R01CA284649-01 · under PAR-21-035 | CARPENTER, MATTHEW JSMITH, TRACY TAYLOR | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $622,093 | IPTA |
| 2023 | Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics1R37CA276317-01A1 · under PAR-21-035 | GUAN, YUE | EMORY UNIVERSITY, GA | $615,683 | HSQE |
| 2023 | Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India1R01CA285063-01 · under PAR-21-035 | CARPENTER, CATHERINE LNYAMATHI, ADELINE MSATYANARAYANA, VEENA A | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $610,339 | HIBI |
| 2023 | Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness1R01CA276594-01A1 · under PAR-21-035 | VANDELLEN, MICHELLE RENEE | UNIVERSITY OF GEORGIA, GA | $606,831 | IPTA |
| 2023 | Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors (iLIVE)1R01CA275055-01A1 · under PAR-21-035 | DEMARK-WAHNEFRIED, WENDYWINTERS-STONE, KERRI M | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $587,585 | LCBH |
| 2023 | Strategies for Optimizing a Mailed FIT Program in Appalachia1R01CA282162-01 · under PAR-21-035 | KATZ, MIRA LREITER, PAUL L | OHIO STATE UNIVERSITY, OH | $584,251 | HHD |
| 2023 | Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance1R37CA275916-01 · under PAR-21-035 | SCHROECK, FLORIAN R | VETERANS EDUCATION/RES/ASSN/NORTH/NE, VT | $583,892 | ZRG1 |
| 2023 | Implementing and Evaluating the Cancer Tracking System (CATSystem): A systems level intervention to improve Cervical Cancer screening, treatment referral and follow up in Kenya1R01CA278617-01A1 · under PAR-21-035 | KESSLER, SARAH FINOCCHARIOMABACHI, MARIANNE NATABHONA | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $583,607 | PPAH |
| 2023 | The effectiveness, cost-effectiveness, and budget impact of interventions to improve the delivery of cervical cancer screening in Puerto Rico.1R01CA282424-01 · under PAR-21-035 | DESHMUKH, ASHISH A.ORTIZ, ANA PATRICIA | COMPREHENSIVE CANCER CENTER/ UNIV/PR, PR | $566,891 | ODHS |
| 2023 | A dyadic exercise approach to prevent declines in physical and mental health in couples during radiation treatment for cancer: a hybrid type I efficacy-implementation trial1R01CA277738-01A1 · under PAR-21-035 | WINTERS-STONE, KERRI M | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $560,335 | CMGC |
| 2022 | Promoting Resilience in Early Survivorship among Adolescents and Young Adults with Cancer.1R01CA269574-01 · under PAR-21-035 | ROSENBERG, ABBY RYI-FRAZIER, JOYCE P | SEATTLE CHILDREN'S HOSPITAL, WA | $930,291 | LCBH |
| 2022 | Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)1R01CA259173-01A1 · under PAR-21-035 | ALLAF, MOHAMADHU, JIMKOWALCZYK, KEITHSCHAEFFER, EDWARD MATTHEW | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $733,721 | CONC |
| 2022 | Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation1R01CA260961-01A1 · under PAR-21-035 | FIGUEIRO, MARIANA GROSSVALDIMARSDOTTIR, HEIDDIS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $728,085 | MESH |
| 2022 | Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:1R01CA272678-01 · under PAR-21-035 | BOUTROS, PAUL CHRISTOPHERJONES, LEE W | SLOAN-KETTERING INST CAN RESEARCH, NY | $715,452 | LCBH |
| 2022 | Provider Support and Patient Outreach in Lung Cancer Screening1R01CA258849-01A1 · under PAR-21-035 | MYERS, RONALD E. | THOMAS JEFFERSON UNIVERSITY, PA | $713,095 | CMGC |
| 2022 | The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment1R01CA261639-01A1 · under PAR-21-035 | SHADEL, WILLIAM G | RAND CORPORATION, CA | $711,244 | CIHB |
| 2022 | A behavioral economic intervention for low-income smokers1R37CA252483-01A1 · under PAR-21-035 | ROGERS, ERIN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $688,443 | HPC |
| 2022 | Novel Therapy to Inhibit IPMN Progression1R01CA263575-01A1 · under PAR-21-035 | BATRA, SURINDER K.MALAFA, MOKENGE P. | H. LEE MOFFITT CANCER CTR & RES INST, FL | $686,204 | CONC |
| 2022 | Using real-time data capture to examine affective mechanisms as mediators of physical activity adherence in interventions1R01CA272933-01 · under PAR-21-035 | DUNTON, GENEVIEVE FRIDLUND | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $684,743 | SPIP |
| 2022 | A randomized controlled trial of eSCCIP: An eHealth psychosocial intervention for English and Spanish speaking parents of children with cancer1R01CA258668-01A1 · under PAR-21-035 | CANTER, KIMBERLY | NEMOURS CHILDREN'S HOSPITAL, DELAWARE, DE | $683,323 | CMGC |
| 2022 | Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress1R01CA268521-01A1 · under PAR-21-035 | FISCHER, STACY MROSS, STEPHEN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $681,645 | BMHO |
| 2022 | Improving medication adherence using a CONnected CUstomized Treatment Platform (CONCURxP)1R01CA262312-01A1 · under PAR-21-035 | GRAETZ, ILANASADIGH, GELAREH | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $678,579 | ZRG1 |
| 2022 | Behavioral Economic Approaches for Population-based Colorectal Cancer Screening1R01CA258893-01A1 · under PAR-21-035 | MEHTA, SHIVAN JATIN | UNIVERSITY OF PENNSYLVANIA, PA | $672,627 | HSQE |
| 2022 | Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care1R01CA268932-01A1 · under PAR-21-035 | CANTRELL, JENNIFER | NEW YORK UNIVERSITY, NY | $668,411 | HIBI |
| 2022 | A digital intervention to improve skin self-examination among melanoma survivors1R01CA264548-01A1 · under PAR-21-035 | HECKMAN, CAROLYNMANNE, SHARON L | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $664,230 | SIHH |
| 2022 | REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE)1R01CA266995-01A1 · under PAR-21-035 | SOHL, STEPHANIE JEAN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $659,522 | BMHO |
| 2022 | Fit2ThriveMIND: Optimizing a mHealth Physical Activity Intervention with Mindful Awareness Lessons in Breast Cancer Survivors1R01CA266178-01A1 · under PAR-21-035 | PHILLIPS, SIOBHAN MARIEVICTORSON, DAVID | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $655,828 | ZRG1 |
| 2022 | Empowering Latinas to Obtain Guideline-Concordant Breast Cancer Screenings1R01CA261638-01A1 · under PAR-21-035 | MOLINA, YAMILE | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $655,642 | HPC |
| 2022 | Improving smoking abstinence outcomes in the African American community through extended treatment1R01CA259256-01A1 · under PAR-21-035 | COX, LISA SANDERSON | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $655,179 | ARM |
| 2022 | Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial1R01CA271220-01 · under PAR-21-035 | RINI, CHRISTINE | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $653,640 | ZRG1 |
| 2022 | Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress1R01CA267107-01 · under PAR-21-035 | BONA, KIRA O.ROSENBERG, ABBY R | DANA-FARBER CANCER INST, MA | $651,395 | SPIP |
| 2022 | Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors1R01CA263714-01A1 · under PAR-21-035 | BADGER, TERRY ASIKORSKII, ALLA | UNIVERSITY OF ARIZONA, AZ | $650,104 | BMHO |
| 2022 | Hybrid Type 1 Effectiveness-Implementation Trial of a Proactive Smoking Cessation Electronic Visit for Scalable Delivery via Primary Care1R01CA258669-01A1 · under PAR-21-035 | DAHNE, JENNIFER RENEE | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $649,204 | SIHH |
| 2022 | Multilevel health system intervention to increase surveillance colonoscopy for high-risk colorectal polyps1R01CA271034-01 · under PAR-21-035 | MAY, FOLASADE POPOOLA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $647,435 | HSQE |
| 2022 | High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients1R01CA258349-01A1 · under PAR-21-035 | PEPPONE, LUKE JOSEPH | UNIVERSITY OF ROCHESTER, NY | $635,824 | ICSC |
| 2022 | Targeted Prevention of Postpartum-Related Breast Cancer (PRBC)1R01CA262393-01A1 · under PAR-21-035 | RADISKY, DEREK CRUDDY, KATHRYN JEANSHERMAN, MARK E | MAYO CLINIC JACKSONVILLE, FL | $627,061 | CPSS |
| 2022 | Early clinial trials for Angelica herbal supplements for prostate cancer interception1R01CA260901-01A1 · under PAR-21-035 | JOSHI, MONIKALU, JUNXUAN | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $623,285 | CPSS |
| 2022 | Novel dietary interventions for reducing obesity-associated breast cancer1R01CA258766-01A1 · under PAR-21-035 | CATENACCI, VICTORIA AKABOS, PETERMACLEAN, PAUL S. | UNIVERSITY OF COLORADO DENVER, CO | $606,900 | CPSS |
| 2022 | Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention1R01CA258757-01A1 · under PAR-21-035 | MALLERY, SUSAN R | OHIO STATE UNIVERSITY, OH | $581,591 | CPSS |
| 2022 | Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia1R01CA254270-01A1 · under PAR-21-035 | ONDREY, FRANK G. | UNIVERSITY OF MINNESOTA, MN | $321,566 | CPSS |
| 2022 | Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients1R01CA262041-01A1 · under PAR-21-035 | HUBERTY, JENNIFER LYNNEMESA, RUBEN A. | CALM.COM, INC., CA | $95,759 | MESH |
| 2021 | Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy1R01CA247517-01A1 · under PAR-18-559 | KOLB, NOAH ALLANMOONEY, KATHLEEN HSMITH, A. GORDON | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE, VT | $1,170,573 | CMPC |
| 2021 | The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors1R01CA256660-01A1 · under PAR-18-559 | CHIAO, ELIZABETH Y.DESHMUKH, ASHISH A.SIGEL, KEITH MAGNUS | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $916,003 | HSQE |
| 2021 | Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer1R01CA249437-01A1 · under PAR-18-559 | FABIAN, CAROL J. | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $852,459 | CPSS |
| 2021 | RESPECT3: A Randomized type 1 hybrid Effectiveness-implementation Study of returning actionable genetic PanEl researCh resulTs2R01CA190871-06A1 · under PAR-18-559 | BRADBURY, ANGELA R. | UNIVERSITY OF PENNSYLVANIA, PA | $791,997 | ZRG1 |
| 2021 | The ASPIRES Study: Activating Cancer Survivors and their Primary Care Providers to Increase Colorectal Cancer Screening1R01CA255269-01 · under PAR-18-559 | HENDERSON, TARA OLIVEKIM, KAREN E | UNIVERSITY OF CHICAGO, IL | $748,224 | PRDP |
| 2021 | Empathic Communication Skills Training to Reduce Lung Cancer Stigma1R01CA255522-01A1 · under PAR-18-559 | BANERJEE, SMITAOSTROFF, JAMIE S. | SLOAN-KETTERING INST CAN RESEARCH, NY | $734,084 | ICSC |
| 2021 | Multilevel Interventions to Increase Adherence to Lung Cancer Screening1R01CA262015-01 · under PAR-18-559 | WERNLI, KAREN J | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $712,200 | HSQE |
| 2021 | Optimization of a remote intervention to improve nutrition and physical activity in colorectal cancer survivors1R37CA248774-01A1 · under PAR-18-559 | VAN BLARIGAN, ERIN LYNN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $705,777 | PRDP |
| 2021 | Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health1R01CA251754-01A1 · under PAR-18-559 | MONTGOMERY, GUY H | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $702,634 | PRDP |
| 2021 | Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules1R01CA252964-01A1 · under PAR-18-559 | BARON, ANNA EGROGAN, ERIC L | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $700,695 | CONC |
| 2021 | Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes1R01CA252211-01A1 · under PAR-18-559 | IRWIN, SCOTT ASPIEGEL, BRENNAN | CEDARS-SINAI MEDICAL CENTER, CA | $694,136 | BMIO |
| 2021 | Cancer Immune-Interception for Lynch Syndrome1R01CA257375-01 · under PAR-18-559 | LIPKIN, STEVEN MVILAR SANCHEZ, EDUARDO | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $692,579 | ZRG1 |
| 2021 | Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial1R01CA262894-01 · under PAR-18-559 | GALARRAGA, OMARWILLIAMS, DAVID M | BROWN UNIVERSITY, RI | $683,723 | LCBH |
| 2021 | Trial of Statins for Chemoprevention in Hepatocellular Carcinoma1R01CA255621-01A1 · under PAR-18-559 | CHUNG, RAYMOND THOSHIDA, YUJIN | MASSACHUSETTS GENERAL HOSPITAL, MA | $675,855 | CPSS |
| 2021 | Identifying modifiable factors that reduce the burden of late stage melanoma in Hispanics1R01CA252182-01A1 · under PAR-18-559 | COCKBURN, MYLES GMILLER, KIMBERLY ANN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $675,213 | HDEP |
| 2021 | Promoting HPV Vaccination among Young Adults in Texas1R01CA248216-01A1 · under PAR-18-559 | LU, QIAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $671,898 | CLHP |
| 2021 | Establishing smoke-free homes with families involved in child protective services: An effectiveness-implementation trial of an integrated program1R01CA248551-01A1 · under PAR-18-559 | KEGLER, MICHELLE CSELF-BROWN, SHANNON RENEE | GEORGIA STATE UNIVERSITY, GA | $670,837 | DIRH |
| 2021 | Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk1R01CA250390-01A1 · under PAR-18-559 | FITZGIBBON, MARIAN L.TUSSING-HUMPHREYS, LISA | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $669,294 | CPSS |
| 2021 | Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care1R01CA258311-01 · under PAR-18-559 | WASHINGTON, KARLA | WASHINGTON UNIVERSITY, MO | $666,584 | CMPC |
| 2021 | CONNECT: COmpreheNsive traiNing and Engagement in Cessation Treatment1R01CA255016-01A1 · under PAR-18-559 | BAILEY, STEFFANI R | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $660,260 | HPC |
| 2021 | Reducing cervical cancer screening disparities in Somali immigrant women through a primary care based HPV self-sampling intervention1R01CA248558-01A1 · under PAR-18-559 | PRATT, REBEKAH J.WINER, RACHEL L. | UNIVERSITY OF MINNESOTA, MN | $657,387 | DIRH |
| 2021 | Writing to Heal: A Culturally Based Brief Expressive Writing Intervention for Chinese Immigrant Breast Cancer Survivors1R01CA248213-01A1 · under PAR-18-559 | LU, QIAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $657,316 | SPIP |
| 2021 | Acceptance and Commitment Therapy for Fear of Recurrence in Breast Cancer Survivors1R01CA255480-01A1 · under PAR-18-559 | JOHNS, SHELLEY A. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $655,048 | CMGC |
| 2021 | SPHERE (Survivorship Plan Health Record) Implementation Trial1R01CA241143-01A1 · under PAR-18-559 | HAGGSTROM, DAVID ANDREW | INDIANA UNIVERSITY INDIANAPOLIS, IN | $649,730 | DIRH |
| 2021 | Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.1R01CA257523-01 · under PAR-18-559 | CHAN, ANDREW TSTAPPENBECK, THADDEUS SYILMAZ, OMER | MASSACHUSETTS GENERAL HOSPITAL, MA | $649,181 | CPSS |
| 2021 | Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women1R01CA247791-01A1 · under PAR-18-559 | CHANG, JUDY CPOLLAK, KATHRYN I | DUKE UNIVERSITY, NC | $648,264 | CMPC |
| 2021 | Efficacy of a self-advocacy serious game intervention for women with advanced cancer1R37CA262025-01 · under PAR-18-559 | THOMAS, TERESA HAGAN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $646,893 | BMHO |
| 2021 | Effect of Helpers Program On-line Training on Smoking Relapse and Social Networks1R01CA248658-01A1 · under PAR-18-559 | MURAMOTO, MYRA L. | UNIVERSITY OF ARIZONA, AZ | $645,082 | IPTA |
| 2021 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults1R01CA251451-01A1 · under PAR-18-559 | KENDZOR, DARLA ELIZABETH | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK | $638,669 | IPTA |
| 2021 | Metformin for chemoprevention of lung cancer in obese subjects at high risk1R01CA255515-01A1 · under PAR-18-559 | BARBI, JOSEPHREID, MARY EYENDAMURI, SAIKRISHNA | ROSWELL PARK CANCER INSTITUTE CORP, NY | $630,457 | CPSS |
| 2021 | Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training1R37CA252060-01A1 · under PAR-18-559 | EHLERS, DIANE KRISTEN | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $603,299 | BMIO |
| 2021 | An Addictions Neuroclinical Assessment Based Treatment for Smokers with an Alcohol Use Disorder1R01CA252185-01A1 · under PAR-18-559 | MCPHERSON, STERLING M | WASHINGTON STATE UNIVERSITY, WA | $600,704 | IPTA |
| 2021 | Testing a culturally targeted narrative video to reduce disparities in the use of genetic counseling and testing in Latina women at-risk of HBOC1R01CA248543-01A1 · under PAR-18-559 | HURTADO DE MENDOZA CASAUS, ALEJANDRA | GEORGETOWN UNIVERSITY, DC | $596,045 | HDEP |
| 2021 | A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention via Electronic Health Record Portal vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer1R01CA248739-01A1 · under PAR-18-559 | KATZ, MIRA LSWEET, KEVIN M. | OHIO STATE UNIVERSITY, OH | $563,458 | ZRG1 |
| 2021 | Evaluating a mobile application to reduce distress in breast cancer survivors using an adaptive design1R37CA248434-01A1 · under PAR-18-559 | CHOW, PHILIP | UNIVERSITY OF VIRGINIA, VA | $518,789 | APDA |
| 2021 | MyGI Diet for Colorectal Cancer Prevention1R01CA255743-01A1 · under PAR-18-559 | BUIS, LORRAINE RDJURIC, ZORA | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $511,916 | CPSS |
| 2020 | Extending the Diversity, Reach, and Generalizability of the WISDOM Study1R01CA237533-01A1 · under PAR-18-559 | ESSERMAN, LAURA J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $1,508,351 | CHSA |
Showing the 200 most recent of 288 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.